Kane Biotech Inc. (KNE.V) Research

Headquartered in Winnipeg, Canada, Kane Biotech Inc. is a biotechnology firm established in 2001, focusing on the research, development, and global commercialization of innovative technologies and products engineered to prevent and remove microbial biofilms. The company's diverse portfolio features pet dental hygiene solutions marketed as StrixNB and bluestem, alongside DispersinB for both animal and human wound care. They also provide Alosera brand shampoos for dogs, cats, and horses, and Aledex for medical device coatings. Additional offerings include DermaKB scalp care products, Coactiv+ wound care items, and other specialized products under the goldstem, silkstem, and DermaKB Biofilm brand names.

Market snapshot

Symbol
KNE.V
Price
$0.03
Day change
0.00%
Market cap
$6.2M
P/E ratio
-2.46x
52-week range
0.0275-0.06
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Appili Therapeutics Inc. (APLI.TO)
  • Aptose Biosciences Inc. (APS.TO)
  • Avricore Health Inc. (AVCR.V)
  • CanadaBis Capital Inc. (CANB.V)
  • Restart Life Sciences Corp. (HEAL.CN)
  • Mountain Valley MD Holdings Inc. (MVMD.CN)
  • Telo Genomics Corp. (TELO.V)
  • 1933 Industries Inc. (TGIF.CN)

Open Kane Biotech Inc. (KNE.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.